Evidence map›Paper›PMID 27999094›Full record

ArticleGenome research2017

The epigenetic landscape of Alu repeats delineates the structural and functional genomic architecture of colon cancer cells.

Mireia Jordà, Anna Díez-Villanueva, Izaskun Mallona, Berta Martín, Sergi Lois, Víctor Barrera, Manel Esteller, Tanya Vavouri, Miguel A Peinado

Open access · bronzeAbstract read
In one paragraph

Article in Genome research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Epigenomic insights into common human disease pathology.Cellular and molecular life sciences : CMLS · 2024
    Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Circular RNA in colorectal cancer.Journal of cellular and molecular medicine · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Mireia JordàGermans Trias i Pujol Health Science Research Institute (IGTP), Badalona 08916, Catalonia, Spain.
Anna Díez-VillanuevaGermans Trias i Pujol Health Science Research Institute (IGTP), Badalona 08916, Catalonia, Spain.
Izaskun MallonaGermans Trias i Pujol Health Science Research Institute (IGTP), Badalona 08916, Catalonia, Spain.
Berta MartínGermans Trias i Pujol Health Science Research Institute (IGTP), Badalona 08916, Catalonia, Spain.
Sergi LoisGermans Trias i Pujol Health Science Research Institute (IGTP), Badalona 08916, Catalonia, Spain.
Víctor BarreraGermans Trias i Pujol Health Science Research Institute (IGTP), Badalona 08916, Catalonia, Spain.
Manel EstellerCancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona 08908, Catalonia, Spain.
Tanya VavouriGermans Trias i Pujol Health Science Research Institute (IGTP), Badalona 08916, Catalonia, Spain.
Miguel A PeinadoGermans Trias i Pujol Health Science Research Institute (IGTP), Badalona 08916, Catalonia, Spain.ORCID 0000-0002-4090-793X
Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol · ESInstitució Catalana de Recerca i Estudis Avançats · ESJosep Carreras Leukaemia Research Institute · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer cells exhibit multiple epigenetic changes with prominent local DNA hypermethylation and widespread hypomethylation affecting large chromosomal domains. Epigenome studies often disregard the study of repeat elements owing to technical complexity and their undefined role in genome regulation. We have developed NSUMA (Next-generation Sequencing of UnMethylated Alu), a cost-effective approach allowing the unambiguous interrogation of DNA methylation in more than 130,000 individual Alu elements, the most abundant retrotransposon in the human genome. DNA methylation profiles of Alu repeats have been analyzed in colon cancers and normal tissues using NSUMA and whole-genome bisulfite sequencing. Normal cells show a low proportion of unmethylated Alu (1%-4%) that may increase up to 10-fold in cancer cells. In normal cells, unmethylated Alu elements tend to locate in the vicinity of functionally rich regions and display epigenetic features consistent with a direct impact on genome regulation. In cancer cells, Alu repeats are more resistant to hypomethylation than other retroelements. Genome segmentation based on high/low rates of Alu hypomethylation allows the identification of genomic compartments with differential genetic, epigenetic, and transcriptomic features. Alu hypomethylated regions show low transcriptional activity, late DNA replication, and its extent is associated with higher chromosomal instability. Our analysis demonstrates that Alu retroelements contribute to define the epigenetic landscape of normal and cancer cells and provides a unique resource on the epigenetic dynamics of a principal, but largely unexplored, component of the primate genome.

Indexed as

Epigenesis, GeneticAlu ElementsColonic NeoplasmsCpG IslandsDNA MethylationGenome, HumanGenomicsHigh-Throughput Nucleotide SequencingHumans

Identifiers

PMID27999094
PMCPMC5204336
OpenAlexW2562158244

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.